Galecto (GLTO) Competitors

Galecto (NASDAQ:GLTO) and Equillium (NASDAQ:EQ) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

Do analysts recommend GLTO or EQ?

Galecto currently has a consensus target price of $10.00, suggesting a potential upside of 198.60%. Equillium has a consensus target price of $1.00, suggesting a potential downside of 34.85%. Given Galecto's stronger consensus rating and higher probable upside, equities analysts plainly believe Galecto is more favorable than Equillium.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Galecto	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Equillium	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media prefer GLTO or EQ?

In the previous week, Equillium had 3 more articles in the media than Galecto. MarketBeat recorded 3 mentions for Equillium and 0 mentions for Galecto. Galecto's average media sentiment score of 1.00 beat Equillium's score of -0.67 indicating that Galecto is being referred to more favorably in the media.

Company	Overall Sentiment
Galecto	Positive
Equillium	Negative

Do insiders and institutionals believe in GLTO or EQ?

14.2% of Galecto shares are held by institutional investors. Comparatively, 27.1% of Equillium shares are held by institutional investors. 10.8% of Galecto shares are held by company insiders. Comparatively, 31.6% of Equillium shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has preferable valuation & earnings, GLTO or EQ?

Equillium has higher revenue and earnings than Galecto. Equillium is trading at a lower price-to-earnings ratio than Galecto, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Galecto	N/A	N/A	-$21.44M	-$13.13	-0.26
Equillium	$41.10M	1.33	-$8.07M	-$0.56	-2.74

Which has more risk & volatility, GLTO or EQ?

Galecto has a beta of 1.35, meaning that its share price is 35% more volatile than the S&P 500. Comparatively, Equillium has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500.

Is GLTO or EQ more profitable?

Galecto has a net margin of 0.00% compared to Equillium's net margin of -19.62%. Galecto's return on equity of -115.70% beat Equillium's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Galecto	N/A	-115.70%	-95.42%
Equillium	-19.62%	-139.56%	-90.56%

Summary

Galecto beats Equillium on 8 of the 15 factors compared between the two stocks.